All Stories

  1. Efficacy and safety of bright light therapy for bipolar depression

    Article • Psychiatry and Clinical Neurosciences, May 2020, Wiley

    Dr Mario F. Juruena

  2. Posttraumatic stress disorder and neuroprogression: a study protocol of the increase of allostatic load and acceleration of the aging process following trauma (Preprint)

    Article • April 2020, JMIR Publications Inc.

    Dr Mario F. Juruena

  3. The Role of Early Life Stress in HPA Axis and Anxiety

    Article • January 2020, Springer Science + Business Media

    Dr Mario F. Juruena

  4. Has the sun set for seasonal affective disorder and HPA axis studies? A systematic review and future prospects

    Article • Journal of Affective Disorders, September 2019, Elsevier

    Dr Mario F. Juruena

  5. Child Abuse and Neglect as Risk Factors for Comorbidity Between Depression and Chronic Pain in Adulthood

    Article • The Journal of Nervous and Mental Disease, July 2019, Wolters Kluwer Health

    Dr Mario F. Juruena

  6. Relationship Between Depression and Subtypes of Early Life Stress in Adult Psychiatric Patients

    Article • Frontiers in Psychiatry, February 2019, Frontiers

    Dr Mario F. Juruena

  7. Bipolar affective disorder and borderline personality disorder: Differentiation based on the history of early life stress and psychoneuroendocrine measures

    Article • Behavioural Brain Research, January 2019, Elsevier

    Dr Mario F. Juruena, Dr Mario Juruena

  8. Genetic biomarkers for differential diagnosis of major depressive disorder and bipolar disorder: A systematic and critical review

    Article • Behavioural Brain Research, January 2019, Elsevier

    Dr Mario F. Juruena

  9. Childhood Sexual Abuse and Indicators of Immune Activity: A Systematic Review

    Article • Frontiers in Psychiatry, August 2018, Frontiers

    Dr Mario F. Juruena

  10. Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review

    Article • Journal of Affective Disorders, June 2018, Elsevier

    Dr Mario F. Juruena

  11. Additional evidence for the classification of a facial expression of anxiety.

    Article • Psychology & Neuroscience, March 2018, American Psychological Association (APA)

    Dr. Vinicius Ferreira Borges, Dr Mario F. Juruena

  12. Is a SIMPLe smartphone application capable of improving biological rhythms in bipolar disorder?

    Article • Journal of Affective Disorders, December 2017, Elsevier

    Dr Mario F. Juruena

  13. The Role of Early Life Stress in HPA Axis and Depression

    Article • October 2017, Springer Science + Business Media

    Dr Mario F. Juruena, Dr Mario Juruena

  14. A translational approach to clinical practice via stress-responsive glucocorticoid receptor signaling

    Article • February 2017, AME Publishing Company

    Dr Mario F. Juruena

  15. Personality disorders

    Article • Medicina (Ribeirão Preto), February 2017, Universidade de Sao Paulo Sistema Integrado de Bibliotecas - SIBiUSP

    Dr Mario F. Juruena

  16. Mental Disorders Diagnostic

    Article • Medicina (Ribeirão Preto), February 2017, Universidade de Sao Paulo Sistema Integrado de Bibliotecas - SIBiUSP

    Dr Mario F. Juruena, Dr Mario Juruena

  17. Pharmacotherapy for general practitioners

    Article • Medicina (Ribeirão Preto), February 2017, Universidade de Sao Paulo Sistema Integrado de Bibliotecas - SIBiUSP

    Dr Mario F. Juruena

  18. Diagnosis of unipolar and bipolar depressions and their specifiers

    Article • Medicina (Ribeirão Preto), February 2017, Universidade de Sao Paulo Sistema Integrado de Bibliotecas - SIBiUSP

    Dr Mario F. Juruena

  19. Trauma and stressor-related disorders

    Article • Medicina (Ribeirão Preto), February 2017, Universidade de Sao Paulo Sistema Integrado de Bibliotecas - SIBiUSP

    Dr Mario F. Juruena, Dr Mario Juruena

  20. Bipolar disorder: a review of conceptual and clinical aspects

    Article • Medicina (Ribeirão Preto), February 2017, Universidade de Sao Paulo Sistema Integrado de Bibliotecas - SIBiUSP

    Dr Mario F. Juruena, Dr. Vinicius Ferreira Borges

  21. Neuropsychological changes in melancholic and atypical depression: A systematic review

    Article • Neuroscience & Biobehavioral Reviews, February 2017, Elsevier

    Dr Mario F. Juruena

  22. Day hospital and psychosocial care center: Expanding the discussion of partial hospitalization in mental health

    Article • Revista da Associação Médica Brasileira, July 2016, FapUNIFESP (SciELO)

    Dr Mario F. Juruena

  23. Burnout in nursing professionals: Associations with early stress

    Article • British Journal of Mental Health Nursing, November 2015, Mark Allen Group

    Dr Mario F. Juruena

  24. Early Life Stress in Depressive Patients: Role of Glucocorticoid and Mineralocorticoid Receptors and of Hypothalamic-Pituitary-Adrenal Axis Activity

    Article • Current Pharmaceutical Design, February 2015, Bentham Science Publishers

    Dr Mario F. Juruena

  25. Factors related to the cortisol awakening response of children working on the streets and siblings, before and after 2 years of a psychosocial intervention

    Article • Psychiatry Research, February 2015, Elsevier

    Dr Mario F. Juruena

  26. INCLUSION OF PATIENTS OF A MENTAL HEALTH DAY HOSPITAL: A REVIEW

    Article • Psicologia Saúde & Doença, November 2014, Sociedad Portuguesa de Psicologia da Saude

    Dr Mario F. Juruena

  27. Emotional Abuse in Childhood Is a Differential Factor for the Development of Depression in Adults

    Article • The Journal of Nervous and Mental Disease, November 2014, Wolters Kluwer Health

    Dr Mario F. Juruena

  28. P.2.b.040 MR and GR balance predicts treatment outcome in treatment resistant depression

    Article • European Neuropsychopharmacology, October 2014, Elsevier

    Dr Mario F. Juruena

  29. Early-life stress and HPA axis trigger recurrent adulthood depression

    Article • Epilepsy & Behavior, September 2014, Elsevier

    Dr Mario F. Juruena, Dr Mario Juruena

  30. Avaliação do funcionamento do eixo HPA em deprimidos por meio de medidas basais: revisão sistemática da literatura e análise das metodologias utilizadas

    Article • Jornal Brasileiro de Psiquiatria, September 2014, FapUNIFESP (SciELO)

    Dr Mario F. Juruena

  31. Long-term symptomatic and functional outcome following an intensive inpatient multidisciplinary intervention for treatment-resistant affective disorders

    Article • Journal of Affective Disorders, September 2014, Elsevier

    Dr Mario F. Juruena

  32. Early Life Stress in Depressive Patients: HPA Axis Response to GR and MR Agonist

    Article • Frontiers in Psychiatry, January 2014, Frontiers

    Dr Mario F. Juruena

  33. The impact of childhood adversity on suicidality and clinical course in treatment-resistant depression

    Article • Journal of Affective Disorders, January 2014, Elsevier

    Dr Mario F. Juruena

  34. The Role of Early Life Stress in Adult Psychiatric Disorders

    Article • The Journal of Nervous and Mental Disease, December 2013, Wolters Kluwer Health

    Dr Mario F. Juruena

  35. P.2.b.050 Mineralocorticoid receptor function a predictor of treatment response in depression with or without early life stress

    Article • European Neuropsychopharmacology, October 2013, Elsevier

    Dr Mario F. Juruena

  36. Pharmacological and Psychosocial Management of Mental, Neurological and Substance Use Disorders in Low- and Middle-Income Countries: Issues and Current Strategies

    Article • Drugs, September 2013, Springer Science + Business Media

    Dr Mario F. Juruena

  37. The role of mineralocorticoid receptor function in treatment-resistant depression

    Article • Journal of Psychopharmacology, July 2013, SAGE Publications

    Dr Mario F. Juruena

  38. Effectiveness of psychoeducation for depression: A systematic review

    Article • Australian & New Zealand Journal of Psychiatry, June 2013, SAGE Publications

    Dr Mario F. Juruena

  39. Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system

    Article • Journal of Affective Disorders, May 2013, Elsevier

    Dr Mario F. Juruena

  40. An exploratory dimensional approach to premenstrual manifestation of obsessive–compulsive disorder symptoms: A multicentre study

    Article • Journal of Psychosomatic Research, April 2013, Elsevier

    Dr Mario F. Juruena

  41. 2204 – Differential diagnosis between bipolar disorder and borderline personality disorder based on early life stress and psychoneuroendocrine assessment

    Article • European Psychiatry, January 2013, Elsevier

    Dr Mario F. Juruena

  42. Antipsychotic agents: efficacy and safety in schizophrenia

    Article • Drug Healthcare and Patient Safety, November 2012, Taylor & Francis

    Dr Mario F. Juruena, Dr Arão Araújo, Irismar Reis de Oliveira, Dr Mario Juruena

  43. Plasma cortisol in first episode drug-naïve mania: Differential levels in euphoric versus irritable mood

    Article • Journal of Affective Disorders, April 2012, Elsevier

    Dr Mario F. Juruena

  44. Cognitive-Behavioral Therapy for the Bipolar Disorder Patients

    Article • March 2012, IntechOpen

    Dr Mario F. Juruena, Dr Mario Juruena

  45. Clinical, Research and Treatment Approaches to Affective Disorders

    Article • February 2012, IntechOpen

    Dr Mario F. Juruena, Dr Mario Juruena

  46. Assessment of the hypothalamic–pituitary–adrenal axis activity: glucocorticoid receptor and mineralocorticoid receptor function in depression with early life stress – a systematic review

    Article • Acta Neuropsychiatrica, February 2012, Cambridge University Press

    Dr Mario F. Juruena

  47. Effects of lithium on oxidative stress parameters in healthy subjects

    Article • Molecular Medicine Reports, December 2011, Spandidos Publications

    Dr Mario F. Juruena

  48. P.2.c.030 The role of mineralocorticoid receptor function in treatment resistant depression M.F. Juruena

    Article • European Neuropsychopharmacology, September 2011, Elsevier

    Dr Mario F. Juruena

  49. Specific mechanism of action of amisulpride in the treatment of schizophrenia and correlation with clinical response and tolerability

    Article • Journal of Receptor Ligand and Channel Research, August 2011, Taylor & Francis

    Dr Mario F. Juruena, Irismar Reis de Oliveira

  50. An integrative science approach: neuroscience in the DSM-V and ICD-11.

    Article • Acta Neuropsychiatrica, August 2011, Cambridge University Press

    Dr Mario F. Juruena

  51. Efficacy of psychoeducation in bipolar patients: Systematic review of randomized trials.

    Article • Psychology & Neuroscience, July 2011, American Psychological Association (APA)

    Dr Mario F. Juruena

  52. Prospective evaluation of specialist inpatient treatment for refractory affective disorders

    Article • Journal of Affective Disorders, June 2011, Elsevier

    Dr Mario F. Juruena

  53. Latin American Studies in Melancholia

    Article • Brazilian Journal of Psychiatry, May 2011, FapUNIFESP (SciELO)

    Dr Mario F. Juruena

  54. Evaluation of hippocampal volume based on MR imaging in patients with bipolar affective disorder applying manual and automatic segmentation techniques

    Article • Journal of Magnetic Resonance Imaging, February 2011, Wiley

    Dr Mario F. Juruena

  55. Early life stress, HPA axis, and depression.

    Article • Psychology & Neuroscience, January 2011, American Psychological Association (APA)

    Dr Mario F. Juruena

  56. Analysis of the occurrence of early life stress in adult psychiatric patients: A systematic review.

    Article • Psychology & Neuroscience, January 2011, American Psychological Association (APA)

    Dr Mario F. Juruena

  57. Sertindole in the Management of Schizophrenia

    Article • Journal of Central Nervous System Disease, January 2011, SAGE Publications

    Dr Mario F. Juruena

  58. The prednisolone suppression test in depression: Dose–response and changes with antidepressant treatment

    Article • Psychoneuroendocrinology, November 2010, Elsevier

    Dr Mario F. Juruena

  59. Safety and tolerability of antipsychotics: focus on amisulpride

    Article • Drug Healthcare and Patient Safety, October 2010, Taylor & Francis

    Dr Mario F. Juruena, Irismar Reis de Oliveira, Dr Mario Juruena

  60. P.2.a.031 Prednisolone suppression test, but not dexamethasone predicts outcome in treatment resistant depression

    Article • European Neuropsychopharmacology, August 2010, Elsevier

    Dr Mario F. Juruena

  61. Longer-term outcome of treatment resistant depression after specialist, multimodal, inpatient treatment: A prospective follow up study

    Article • Journal of Affective Disorders, April 2010, Elsevier

    Dr Mario F. Juruena

  62. Amygdala activation to masked happy facial expressions

    Article • Journal of the International Neuropsychological Society, December 2009, Cambridge University Press

    Professor Cynthia H.Y, Fu, Dr Mario F. Juruena

  63. In vivo evaluation of cortical thickness with magnetic resonance imaging in patients with bipolar disorder

    Article • Psicologia Teoria e Pesquisa, December 2009, FapUNIFESP (SciELO)

    Dr Mario F. Juruena

  64. Exposição ao chumbo: consequências neuropsiquiátricas e comportamentais

    Article • Medicina (Ribeirão Preto), September 2009, Universidade de Sao Paulo Sistema Integrado de Bibliotecas - SIBiUSP

    Dr Mario F. Juruena

  65. P.2.b.014 Four days of citalopram increase in vitro glucocorticoid receptor function in healthy volunteers

    Article • European Neuropsychopharmacology, September 2009, Elsevier

    Dr Mario F. Juruena

  66. In vivo evaluation of cortical thickness with magnetic resonance imaging in patients with bipolar disorder.

    Article • Psychology & Neuroscience, July 2009, American Psychological Association (APA)

    Dr Mario F. Juruena

  67. Reply: ‘Clomipramine and Glucocorticoid Receptor Function’

    Article • Neuropsychopharmacology, May 2009, Nature

    Dr Mario F. Juruena

  68. Revisão das diretrizes da Associação Médica Brasileira para o tratamento da depressão (Versão integral)

    Article • Brazilian Journal of Psychiatry, May 2009, FapUNIFESP (SciELO)

    Dr Marcelo Berlim, Dr Mario F. Juruena

  69. Prednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistance

    Article • The British Journal of Psychiatry, March 2009, Royal College of Psychiatrists

    Dr Mario F. Juruena

  70. Bipolar I and II disorder residual symptoms: Oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, February 2009, Elsevier

    Dr Mario F. Juruena

  71. The ratio of cortisol/DHEA in treatment resistant depression

    Article • Psychoneuroendocrinology, January 2009, Elsevier

    Dr Mario F. Juruena

  72. Improved stress response in bipolar affective disorder with adjunctive spironolactone (mineralocorticoid receptor antagonist): case series

    Article • Journal of Psychopharmacology, June 2008, SAGE Publications

    Dr Mario F. Juruena, Dr Mario Juruena

  73. Clomipramine In Vitro Reduces Glucocorticoid Receptor Function in Healthy Subjects but not in Patients with Major Depression

    Article • Neuropsychopharmacology, March 2008, Nature

    Dr Mario F. Juruena

  74. S.07.05 Prednisolone suppression test as a predictor of outcome in treatment resistant depression

    Article • European Neuropsychopharmacology, October 2007, Elsevier

    Dr Mario F. Juruena

  75. P.2.a.033 Treatment resistant depression: prednisolone suppression test predicts response to inpatient treatment

    Article • European Neuropsychopharmacology, October 2007, Elsevier

    Dr Mario F. Juruena

  76. Um paradigma para entender e tratar as doenças psiquiátricas

    Article • Brazilian Journal of Psychiatry, May 2007, FapUNIFESP (SciELO)

    Dr Mario F. Juruena

  77. Superposição entre depressão atípica, doença afetiva sazonal e síndrome da fadiga crônica

    Article • Brazilian Journal of Psychiatry, May 2007, FapUNIFESP (SciELO)

    Dr Mario F. Juruena

  78. Depressão e estresse: existe um endofenótipo?

    Article • Brazilian Journal of Psychiatry, May 2007, FapUNIFESP (SciELO)

    Dr Mario F. Juruena

  79. P.3.18 Prednisolone suppression test as a predictor of outcome in treatment resistant depression

    Article • European Neuropsychopharmacology, March 2007, Elsevier

    Dr Mario F. Juruena

  80. Treatment of psychosis: 30 years of progress

    Article • Journal of Clinical Pharmacy and Therapeutics, November 2006, Wiley

    Dr Mario F. Juruena

  81. Different responses to dexamethasone and prednisolone in the same depressed patients

    Article • Psychopharmacology, October 2006, Springer Science + Business Media

    Dr Mario F. Juruena

  82. Glucocorticoid sensitivity in whole blood cells from healthy volunteers: effect of antidepressants

    Article • European Neuropsychopharmacology, January 2006, Elsevier

    Dr Mario F. Juruena

  83. P.2.a.003 Treatment resistant depression: response to prednisolone supression test

    Article • European Neuropsychopharmacology, January 2006, Elsevier

    Dr Mario F. Juruena

  84. P.4.10 Different response to a dexamethasone and prednisolone test in treatment-resistant depressed patients

    Article • European Neuropsychopharmacology, January 2005, Elsevier

    Dr Mario F. Juruena

  85. Distimia: características históricas e nosológicas e sua relação com transtorno depressivo maior

    Article • Revista de Psiquiatria do Rio Grande do Sul, December 2004, FapUNIFESP (SciELO)

    Dr Lucas Spanemberg , Dr Mario F. Juruena

  86. O eixo hipotálamo-pituitária-adrenal, a função dos receptores de glicocorticóides e sua importância na depressão

    Article • Brazilian Journal of Psychiatry, September 2004, FapUNIFESP (SciELO)

    Dr Mario F. Juruena

  87. Molecular mechanisms of glucocorticoid receptor sensitivity and relevance to affective disorders

    Article • Acta Neuropsychiatrica, December 2003, Cambridge University Press

    Dr Mario F. Juruena

  88. Diretrizes da Associação Médica Brasileira para o tratamento da depressão (versão integral)

    Article • Brazilian Journal of Psychiatry, June 2003, FapUNIFESP (SciELO)

    Dr Mario F. Juruena

  89. Lithium reduces maternal child abuse behaviour: a preliminary report

    Article • Journal of Clinical Pharmacy and Therapeutics, August 2001, Wiley

    Dr Mario F. Juruena

  90. Double-blind comparison of venlafaxine and amitriptyline in outpatients with major depression with or without melancholia

    Article • Journal of Psychopharmacology, January 2000, SAGE Publications

    Dr Mario F. Juruena

  91. Confiabilidade diagnóstica dos transtornos mentais da versão para cuidados primários da Classificação Internacional das Doenças

    Article • Revista de Saúde Pública, October 1999, FapUNIFESP (SciELO)

    Dr Mario F. Juruena

  92. The role of depression in coronary artery disease

    Article • Arquivos Brasileiros de Cardiologia, August 1999, FapUNIFESP (SciELO)

    Dr Mario F. Juruena

  93. Moclobemide effects on prolactin plasma levels in healthy individuals

    Article • International Clinical Psychopharmacology, November 1997, Wolters Kluwer Health

    Dr Mario F. Juruena

  94. Abstracts and Reviews : 2. South America

    Article • Transcultural Psychiatric Research Review, January 1992, SAGE Publications

    Dr Mario F. Juruena

  95. Bergara, Dr Mario

    Article • Brill

    Dr Mario F. Juruena